Aspirin in the primary prevention of cardiovascular disease and colon cancer

Hailey D, Harstall C
Record ID 31998008132
English
Authors' objectives: To assess the evidence of effectiveness and safety in the prophylactic use of acetylsalicylic acid in the primary prevention of myocardial infarction, stroke and colon cancer.
Authors' recomendations: There is insufficient evidence to support the prophylactic use of ASA in the general population to reduce the risk of myocardial infarction, stroke and colon cancer. ASA prophylaxis is effective in various groups who are at high risk for cardiovascular disease. However, more effective treatments are available for some conditions, such as atrial fibrillation, which are associated with a high risk of stroke, though such treatments are associated with a higher risk of complications.
Authors' methods: Systematic review
Details
Project Status: Completed
Year Published: 1997
English language abstract: An English language summary is available
Publication Type: Not Assigned
Country: Canada
MeSH Terms
  • Cerebrovascular Disorders
  • Colorectal Neoplasms
  • Myocardial Infarction
  • Aspirin
Contact
Organisation Name: Institute of Health Economics
Contact Address: 1200, 10405 Jasper Avenue, Edmonton, Alberta, Canada, T5J 3N4. Tel: +1 780 448 4881; Fax: +1 780 448 0018;
Contact Name: djuzwishin@ihe.ca
Contact Email: djuzwishin@ihe.ca
Copyright: Alberta Heritage Foundation for Medical Research, 1997
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.